Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000950170-25-112500·Carisma Therapeutics Inc.
Schedule 13D ownership disclosure
CARISMA THERAPEUTICS INC
Common Stock, $0.001 par value per share · CUSIP: 14216R101
Event date: 2025-09-02
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- HealthCap VII, L.P.Reported CIK 0001645161
Shares: 0 · Class: 0.0%
- HealthCap VII GP LLC
Shares: 0 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950170-25-112500
- Form type
- SCHEDULE 13D/A
- Filer
- Carisma Therapeutics Inc.
- CIK
- CIK 1485003
- Filed
- Sep 02, 2025
- Reporting period
- Sep 02, 2025
- Description
- Schedule 13D beneficial ownership